Young SMA patient’s ongoing campaign aims to raise S$375,000 for vital treatment since March 2023
Despite positive progress in the crowdfunding for baby Lucas, another 24-year-old Spinal Muscular Atrophy (SMA) Type 2 patient is seeking community help to raise S$375,000 for treatment.
The high cost of Risdiplam, an oral medication vital for stabilizing SMA progression, poses a significant obstacle for patients like Ms. Toh in accessing life-saving treatment.